Spyre Therapeutics, Inc. (SYRE)

76.44 +4.44 (+6.17%) USD  |  NASDAQ  |  Jun 09, 16:00
75.39 -1.05 (-1.37%) Pre-Market: 09:18
More

Spyre Therapeutics Total Operating Expenses (Quarterly)

Total Operating Expenses (Quarterly) Chart

View Total Operating Expenses (Quarterly) for SYRE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Operating Expenses (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Operating Expenses (Quarterly) Range, Past 5 Years

View Total Operating Expenses (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Operating Expenses (Quarterly) Benchmarks

View Total Operating Expenses (Quarterly) Benchmarks
Start Trial
Praxis Precision Medicines, Inc. Upgrade
Viridian Therapeutics, Inc. Upgrade
Relay Therapeutics, Inc. Upgrade
Damora Therapeutics, Inc. Upgrade
Savara, Inc. Upgrade